Medical and Pharmaceutical Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial KB707 demonstrated a 27% objective response rate and 73% disease control rate Rowan DunneDecember 19, 2024
Medical and Pharmaceutical Scientists develop scan technique to light up aggressive lung cancer ‘like a Christmas tree’ More treatment innovation just in time for the holidays Rowan DunneDecember 18, 2024
Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Medical and Pharmaceutical Cizzle Biotechnology expands lung cancer blood biopsy test distribution into Caribbean This UK oncology company was spun out from the University of York's Department of Biology Rowan DunneDecember 16, 2024
Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024
Medical and Pharmaceutical University of Cambridge develops ‘zombie’ cell detecting lung cancer urine test It is not the first pee test used to help diagnose the disease, but it is the first of its kind Rowan DunneDecember 6, 2024
Health & Wellness BC woman advocates for lung cancer screening after shocking diagnosis at 39 Even if you have a healthy lifestyle and don't smoke you should still get checked out, she says Rowan DunneNovember 28, 2024
Medical and Pharmaceutical Kentucky governor recognizes Lung Cancer Awareness Month with formal proclamation Kentucky has the highest rate of the disease in the country, largely attributable to a vast number of smokers Rowan DunneNovember 26, 2024
Medical and Pharmaceutical GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most The first patient has been screened with the R&D-stage test in a Phase III study Rowan DunneNovember 19, 2024
Medical and Pharmaceutical Korean consortium propels lung cancer drug development with AI, supercomputers It is being led by Seoul's bioscience company J INTS BIO Rowan DunneNovember 18, 2024